Asmaa El-Kenawi
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
89
Citations
1,963
Est. group size
—
Recurring co-author estimate
Active years
16
Publishing since 2011
Asmaa El-Kenawi studies the biology of prostate cancer, with a particular focus on how tumor metabolism and the surrounding cellular environment influence cancer progression and resistance to treatment. Much of the work examines how immune cells such as macrophages and metabolic pathways (involving cholesterol, iron, and one-carbon/methionine metabolism) support tumor growth. Some projects also explore imaging-based tools for predicting prostate cancer.
Publication activity has been steady with periodic peaks, including a notable spike in 2023, averaging roughly 11 publications per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~11 · 12% small-team papers (≤3 authors) · across 19 venues
- Novel Voxel-Based MRI Risk Score LADCT <sub>2</sub> as a Tool for Prediction of Prostate Cancer: A Proof of Concept With Retrospective Study
Cancer Control · 2026
- Author response for "Novel voxel-based MRI risk score LADCT2 as a tool for prediction of prostate cancer: a proof of concept with retrospective study"
2026
- Mapping Mitochondrial Interactions with Endoplasmic Reticulum and Plasma Membrane Under DNA Damage in Prostate Cancer Cells
Proceedings of IMPRS · 2026
- Abstract 6546: Iron accumulation correlates with tumor progression in mouse models of prostate cancer
Cancer Research · 2025
- Loss of ANPEP expression may promote the development of aggressive prostate cancer.
Journal of Clinical Oncology · 2025
- Supplementary Data from Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells
2025
- Supplementary Data from Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells
2025
- Supplementary Data from Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells
2025
- Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes
European Urology Open Science · 2025
- Author response for "Novel voxel-based MRI risk score LADCT2 as a tool for prediction of prostate cancer: a proof of concept with retrospective study"
2025
- Abstract C108: ANPEP regulates one-carbon metabolism in prostate cancer
Cancer Epidemiology Biomarkers & Prevention · 2024
- 8815 ANPEP regulates one-carbon metabolism in prostate cancer
Journal of the Endocrine Society · 2024
- Figure S6 from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
2023
- Data from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
2023
- MP04-17 ALTERATIONS IN RNASET2 FACILITATE A PRO TUMOR MICROENVIRONMENT ASSOCIATED WITH WORSE CLINICAL OUTCOMES IN CLEAR CELL RCC
The Journal of Urology · 2023
- Cancer Research×11
- Science Translational Medicine×6
- bioRxiv (Cold Spring Harbor Laboratory)×6
- The Journal of Urology×3
- British Journal of Cancer×2
- Eswar Shankar
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Faye Zheng
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Lei Chen
Biochemistry, Genetics and Molecular Biology · Indiana University
- Deliang Guo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yongjun Kou
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile